What it is (overview)

A breast MRI with IV contrast (also called a contrast-enhanced breast MRI) is a medical imaging exam performed in a radiology department that uses a powerful magnet and radio waves to create highly detailed pictures of breast tissue. Unlike mammography (which uses X-rays), MRI does not use ionizing radiation. During this exam, a contrast dye (most commonly a gadolinium-based contrast agent) is given through an IV to help highlight areas with increased blood flow, which can be seen with some breast abnormalities including certain cancers.

The exam produces multiple image sequences and “dynamic” post-contrast images that show how breast tissue and any suspicious areas take up and release contrast over time. Radiologists interpret these findings using standardized terminology (often BI-RADS for MRI). The test does not “measure” a single number; instead, it evaluates features such as:

• Presence of a mass or non-mass enhancement
• Size, shape, and margins of an abnormality
• Enhancement pattern (how a spot takes up contrast)
• Extent of disease (single area vs multiple areas, one breast vs both)
• Lymph node appearance (especially in the armpit/axilla)

What results can mean (plain language): A normal/negative MRI means no suspicious contrast-enhancing abnormality was seen. An abnormal MRI means there is an area that looks different from typical breast tissue and may require additional evaluation—such as a targeted ultrasound, diagnostic mammogram, short-interval follow-up MRI, or an MRI-guided biopsy. Importantly, not every finding is cancer; benign (non-cancerous) conditions can also enhance with contrast. Your clinician will interpret the results alongside your symptoms, physical exam, and prior imaging.

When & why it's usually done

A breast MRI with IV contrast is commonly ordered when more detail is needed than a mammogram or ultrasound can provide, or when a person has a higher risk of breast cancer. It is not a routine first test for everyone, but it is a powerful diagnostic test and screening tool in specific situations.

Common reasons your doctor may order this exam include:

• High-risk breast cancer screening, such as people with a known BRCA1/BRCA2 mutation, certain other hereditary cancer syndromes, a strong family history, or prior chest radiation at a young age.
• Further evaluation of an abnormal finding on mammogram or ultrasound, especially if the breasts are very dense or the abnormality is difficult to characterize.
• Assessing the extent of known breast cancer (staging), including checking for additional areas in the same breast, the opposite breast, or involvement near the chest wall.
• Pre-surgical planning (for lumpectomy vs mastectomy decisions) by mapping the size and location of a tumor and any satellite lesions.
• Monitoring response to treatment, such as measuring how a tumor changes during or after chemotherapy (neoadjuvant therapy).
• Evaluating possible recurrence after breast cancer treatment, particularly when scar tissue and recurrent tumor are difficult to tell apart on other imaging.
• Assessment of breast implants (MRI without contrast is often used for rupture; contrast MRI may be used if there is concern for associated masses or other abnormalities).
• Problem-solving for symptoms when other tests are inconclusive, such as a persistent lump, nipple changes, or unexplained findings on physical exam.

Because IV contrast is used, your care team may ask about kidney disease, prior contrast reactions, pregnancy status, and any implanted devices. Many implants and devices are MRI-safe, but it is important to confirm this before the scan.

Common diseases related to it

• Breast cancer (including invasive ductal carcinoma and invasive lobular carcinoma)
• Ductal carcinoma in situ (DCIS)
• Benign breast masses (such as fibroadenoma)
• Breast cysts and complex cystic lesions
• High-risk or atypical lesions (e.g., atypical ductal hyperplasia, lobular carcinoma in situ)
• Mastitis and breast abscess (inflammatory/infectious breast conditions)
• Post-surgical scar tissue vs recurrent tumor after lumpectomy or mastectomy
• Breast implant complications (including rupture or peri-implant abnormalities, when clinically indicated)

Health goals where it may help

• Early detection of breast cancer in people at increased genetic or lifetime risk (enhanced cancer screening)
• Clarifying breast abnormalities found on mammogram or ultrasound to guide next steps
• Accurate tumor detection and mapping to support personalized treatment planning
• Monitoring treatment effectiveness (response assessment during/after therapy)
• Post-treatment surveillance to monitor for recurrence or new cancers
• Supporting overall breast health assessment in complex cases (dense breasts, prior surgery, or inconclusive imaging)